Critical Survey: Catamaran Corp (CTRX) and The Competition
Catamaran Corp (NASDAQ: CTRX) is one of 13 publicly-traded companies in the “Managed Health Care” industry, but how does it contrast to its rivals? We will compare Catamaran Corp to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation.
This table compares Catamaran Corp and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Catamaran Corp Competitors||1.83%||11.42%||3.50%|
Catamaran Corp has a beta of -0.18, indicating that its stock price is 118% less volatile than the S&P 500. Comparatively, Catamaran Corp’s rivals have a beta of 0.68, indicating that their average stock price is 32% less volatile than the S&P 500.
Valuation and Earnings
This table compares Catamaran Corp and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Catamaran Corp Competitors||$50.73 billion||$1.52 billion||9.22|
Catamaran Corp’s rivals have higher revenue and earnings than Catamaran Corp. Catamaran Corp is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Insider and Institutional Ownership
90.7% of shares of all “Managed Health Care” companies are held by institutional investors. 2.6% of shares of all “Managed Health Care” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This is a summary of current ratings and recommmendations for Catamaran Corp and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Catamaran Corp Competitors||81||932||1475||24||2.57|
As a group, “Managed Health Care” companies have a potential downside of 0.37%. Given Catamaran Corp’s rivals higher possible upside, analysts clearly believe Catamaran Corp has less favorable growth aspects than its rivals.
Catamaran Corp rivals beat Catamaran Corp on 7 of the 8 factors compared.
About Catamaran Corp
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies. In addition, the Company is a national provider of drug benefits to its customers under the federal government’s Medicare Part D program. The Company’s HCIT product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company’s customers include organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, self-insured employer groups, unions, third-party healthcare plan administrators, and state and federal government entities.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with MarketBeat.com's FREE daily email newsletter.